Providence Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Providence Therapeutics's estimated annual revenue is currently $12.9M per year.
- Providence Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Providence Therapeutics has 83 Employees.
- Providence Therapeutics grew their employee count by 14% last year.
Providence Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP Finance & Accounting | Reveal Email/Phone |
2 | VP, Process & Analytical Development | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | Director Finance And Accounting | Reveal Email/Phone |
5 | Chief Science Officer | Reveal Email/Phone |
6 | Director Partnerships and Innovation | Reveal Email/Phone |
7 | Director, MSAT | Reveal Email/Phone |
8 | Director, Program and Alliance Management | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Director Formulation | Reveal Email/Phone |
Providence Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Providence Therapeutics?
Providence Therapeutics is a personalized mRNA cancer vaccine company. We are working to ignite the cure within by using the power of the immune system to treat cancer.
keywords:N/A
N/A
Total Funding
83
Number of Employees
$12.9M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Providence Therapeutics News
2022-03-30 - New crop of COVID-19 mRNA vaccines could be easier to ...
A new wave of mRNA COVID-19 vaccines ; Providence Therapeutics, Canada, Conventional ; Arcturus Therapeutics**, United States, Self-amplifying...
2022-03-30 - Everest Medicines Enters into an MOU for Partnership with ...
("Providence") to advance mRNA vaccines and therapies. Under the terms of the agreement, Everest owns the rights Providence's mRNA vaccine...
2022-03-30 - Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical
Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2
Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April
8, 2022, at 1:15 PM ET
Rubius Therapeutics is a clinical-stage biopharmaceutical company ... 2021 Best Places to Work in Rhode Island by Providence Business News.
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12M | 83 | -7% | $44.1M |
#2 | $12M | 83 | -3% | N/A |
#3 | $19.4M | 83 | -3% | N/A |
#4 | $29.3M | 83 | -6% | N/A |
#5 | $26.8M | 83 | -7% | N/A |